"EASY workflow integration for GENe therapy"

The EASYGEN project is a European initiative aimed at optimizing hospital processes associated with advanced therapies, particularly CAR-T cell therapy, in order to improve their accessibility and sustainability. These therapies, despite their potential in cancer treatment, currently face limitations due to their complexity, high cost, and centralized production.

Funded by the European Union, EASYGEN brings together a multidisciplinary consortium to develop an automated platform that allows these therapies to be produced directly in the hospital setting, reducing time and costs and facilitating access to personalized treatments.

Quirónsalud participates by contributing to the evaluation of care processes and the dissemination of results, promoting the generation of knowledge about the patient experience and the development of communication strategies with healthcare professionals and patient associations, with the goal of facilitating the integration of these innovations into clinical practice.